Global Antibiotic R&D Partnership (GARDP)
@gardp.bsky.social
Putting public health needs at the centre of antibiotic drug development to address the crisis of antimicrobial resistance (AMR).
https://gardp.org/this-is-big/
https://gardp.org/this-is-big/
Pinned
👶 Each year, 3M newborns globally are affected by sepsis, making it a leading cause of death in this age group.
GARDP’s landmark NeoSep1 trial is evaluating new antibiotic combinations to improve care for newborns with sepsis.
Watch Carol Ruffell share more this World Children’s Day.
#WAAW2025
GARDP’s landmark NeoSep1 trial is evaluating new antibiotic combinations to improve care for newborns with sepsis.
Watch Carol Ruffell share more this World Children’s Day.
#WAAW2025
🎙️We partnered with DeFrontera on #WAAW2025 for a media science café with African journalists and beyond.
Experts discussed rising newborn infections and drug-resistant gonorrhoea cases, news solutions like the investigational antibiotic zoliflodacin, and why data-led storytelling is essential✍️
Experts discussed rising newborn infections and drug-resistant gonorrhoea cases, news solutions like the investigational antibiotic zoliflodacin, and why data-led storytelling is essential✍️
November 20, 2025 at 11:00 AM
🎙️We partnered with DeFrontera on #WAAW2025 for a media science café with African journalists and beyond.
Experts discussed rising newborn infections and drug-resistant gonorrhoea cases, news solutions like the investigational antibiotic zoliflodacin, and why data-led storytelling is essential✍️
Experts discussed rising newborn infections and drug-resistant gonorrhoea cases, news solutions like the investigational antibiotic zoliflodacin, and why data-led storytelling is essential✍️
Echoing GAP-f’s message on #WorldChildrensDay 👶
This World Children's Day, we reaffirm our shared commitment to develop and accelerate access to safe, effective and age-appropriate medicines for children worldwide.
This World Children's Day, we reaffirm our shared commitment to develop and accelerate access to safe, effective and age-appropriate medicines for children worldwide.
November 20, 2025 at 10:25 AM
Echoing GAP-f’s message on #WorldChildrensDay 👶
This World Children's Day, we reaffirm our shared commitment to develop and accelerate access to safe, effective and age-appropriate medicines for children worldwide.
This World Children's Day, we reaffirm our shared commitment to develop and accelerate access to safe, effective and age-appropriate medicines for children worldwide.
🚨 The latest WHO EGASP report, released during #WAAW2025, highlights alarming increases in drug-resistant gonorrhoea.
⚠️ The findings underscore the urgent need for stronger surveillance, enhanced diagnostic capacity & accelerated access to new STIs' treatments.
🔗https://bit.pulse.ly/zyiupcglh8
⚠️ The findings underscore the urgent need for stronger surveillance, enhanced diagnostic capacity & accelerated access to new STIs' treatments.
🔗https://bit.pulse.ly/zyiupcglh8
Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP): gonorrhoea treatment optimization, 2024 report
The WHO EGASP report presents the latest findings from surveillance, providing quality-assured antimicrobial susceptibility testing data to inform national, regional and global treatment guidelines in participating countries. In the current report (data of 2024), 13 countries across 5 WHO regions participated, with the latest figures including demographic, clinical, and antimicrobial resistance data.
bit.pulse.ly
November 20, 2025 at 9:29 AM
🚨 The latest WHO EGASP report, released during #WAAW2025, highlights alarming increases in drug-resistant gonorrhoea.
⚠️ The findings underscore the urgent need for stronger surveillance, enhanced diagnostic capacity & accelerated access to new STIs' treatments.
🔗https://bit.pulse.ly/zyiupcglh8
⚠️ The findings underscore the urgent need for stronger surveillance, enhanced diagnostic capacity & accelerated access to new STIs' treatments.
🔗https://bit.pulse.ly/zyiupcglh8
👶 Each year, 3M newborns globally are affected by sepsis, making it a leading cause of death in this age group.
GARDP’s landmark NeoSep1 trial is evaluating new antibiotic combinations to improve care for newborns with sepsis.
Watch Carol Ruffell share more this World Children’s Day.
#WAAW2025
GARDP’s landmark NeoSep1 trial is evaluating new antibiotic combinations to improve care for newborns with sepsis.
Watch Carol Ruffell share more this World Children’s Day.
#WAAW2025
November 20, 2025 at 7:03 AM
👶 Each year, 3M newborns globally are affected by sepsis, making it a leading cause of death in this age group.
GARDP’s landmark NeoSep1 trial is evaluating new antibiotic combinations to improve care for newborns with sepsis.
Watch Carol Ruffell share more this World Children’s Day.
#WAAW2025
GARDP’s landmark NeoSep1 trial is evaluating new antibiotic combinations to improve care for newborns with sepsis.
Watch Carol Ruffell share more this World Children’s Day.
#WAAW2025
📊 2025 Milestone from our STIs programme
✅ Investigational first-in-class oral antibiotic, zoliflodacin is now under US FDA review
For the first time in over 40 years, a new treatment for gonorrhoea could soon be within reach.
🔗https://gardp.pulse.ly/ob24h4zm0c
#WAAW2025 #AMR #STI #ThisIsBig
✅ Investigational first-in-class oral antibiotic, zoliflodacin is now under US FDA review
For the first time in over 40 years, a new treatment for gonorrhoea could soon be within reach.
🔗https://gardp.pulse.ly/ob24h4zm0c
#WAAW2025 #AMR #STI #ThisIsBig
November 19, 2025 at 3:59 PM
📊 2025 Milestone from our STIs programme
✅ Investigational first-in-class oral antibiotic, zoliflodacin is now under US FDA review
For the first time in over 40 years, a new treatment for gonorrhoea could soon be within reach.
🔗https://gardp.pulse.ly/ob24h4zm0c
#WAAW2025 #AMR #STI #ThisIsBig
✅ Investigational first-in-class oral antibiotic, zoliflodacin is now under US FDA review
For the first time in over 40 years, a new treatment for gonorrhoea could soon be within reach.
🔗https://gardp.pulse.ly/ob24h4zm0c
#WAAW2025 #AMR #STI #ThisIsBig
Reposted by Global Antibiotic R&D Partnership (GARDP)
Have sex? Be safe:
🛡️ Use a condom
🧪 Get tested regularly
🩺 If you think you have a sexually transmitted infections, don't self-medicate. See a health care professional.
#SafeSex
https://bit.ly/3XAo8we
🛡️ Use a condom
🧪 Get tested regularly
🩺 If you think you have a sexually transmitted infections, don't self-medicate. See a health care professional.
#SafeSex
https://bit.ly/3XAo8we
November 19, 2025 at 12:01 PM
Have sex? Be safe:
🛡️ Use a condom
🧪 Get tested regularly
🩺 If you think you have a sexually transmitted infections, don't self-medicate. See a health care professional.
#SafeSex
https://bit.ly/3XAo8we
🛡️ Use a condom
🧪 Get tested regularly
🩺 If you think you have a sexually transmitted infections, don't self-medicate. See a health care professional.
#SafeSex
https://bit.ly/3XAo8we
As part of #WAAW2025, GARDP’s Pierre Daram participated as a speaker in the WHO webinar - From Resistance to Resilience: Drug-Resistant Gonorrhoea in 2025
The session marked the launch of 2024 EGASP Data Report that underscores the need to preserve surveillance efforts against drug-resistant STIs.
The session marked the launch of 2024 EGASP Data Report that underscores the need to preserve surveillance efforts against drug-resistant STIs.
November 19, 2025 at 1:51 PM
As part of #WAAW2025, GARDP’s Pierre Daram participated as a speaker in the WHO webinar - From Resistance to Resilience: Drug-Resistant Gonorrhoea in 2025
The session marked the launch of 2024 EGASP Data Report that underscores the need to preserve surveillance efforts against drug-resistant STIs.
The session marked the launch of 2024 EGASP Data Report that underscores the need to preserve surveillance efforts against drug-resistant STIs.
Gonorrhoea accounts for over 82 million new cases each year and has had no new treatment in more than 40 years.
GARDP and Innoviva Specialty Therapeutics have co-developed zoliflodacin, an investigational first-in-class oral antibiotic now under FDA review.
THIS IS BIG.
#WAAW2025 #AMR
GARDP and Innoviva Specialty Therapeutics have co-developed zoliflodacin, an investigational first-in-class oral antibiotic now under FDA review.
THIS IS BIG.
#WAAW2025 #AMR
November 19, 2025 at 1:00 PM
Reposted by Global Antibiotic R&D Partnership (GARDP)
#WAAW2025 remind us of the human cost behind #AMR. Their courage and advocacy inspires and push for better prevention, access, and responsible use of antibiotics.We start our #7x7x7 campaign with #suvivors @VanessaCarter. Learn more: buff.ly/7ItwUtv #HealthDiplomacy
November 18, 2025 at 8:33 AM
#WAAW2025 remind us of the human cost behind #AMR. Their courage and advocacy inspires and push for better prevention, access, and responsible use of antibiotics.We start our #7x7x7 campaign with #suvivors @VanessaCarter. Learn more: buff.ly/7ItwUtv #HealthDiplomacy
Reposted by Global Antibiotic R&D Partnership (GARDP)
#WAAW starts tomorrow, despite the rain, the AMR Awareness logo and our flags are already flying along the Mont-Blanc Bridge. Join us in all our activities during #WAAW : buff.ly/7ItwUtv #HealthDiplomacy #7x7x7 #WAAW2025 #ActNow #AMR #OneHealth #DiplomaciaSalud
November 17, 2025 at 8:46 AM
#WAAW starts tomorrow, despite the rain, the AMR Awareness logo and our flags are already flying along the Mont-Blanc Bridge. Join us in all our activities during #WAAW : buff.ly/7ItwUtv #HealthDiplomacy #7x7x7 #WAAW2025 #ActNow #AMR #OneHealth #DiplomaciaSalud
Reposted by Global Antibiotic R&D Partnership (GARDP)
🦠 Every day more than 1 million curable STIs are acquired. Drug-resistant gonorrhoea is spreading and treatment options are running out.
GARDP is acting now to change this. In this video, Yann Ferrisse explains how we are working on new solutions.
#WAAW2025 #AMR #Antibiotics #STIs
GARDP is acting now to change this. In this video, Yann Ferrisse explains how we are working on new solutions.
#WAAW2025 #AMR #Antibiotics #STIs
November 19, 2025 at 7:01 AM
🦠 Every day more than 1 million curable STIs are acquired. Drug-resistant gonorrhoea is spreading and treatment options are running out.
GARDP is acting now to change this. In this video, Yann Ferrisse explains how we are working on new solutions.
#WAAW2025 #AMR #Antibiotics #STIs
GARDP is acting now to change this. In this video, Yann Ferrisse explains how we are working on new solutions.
#WAAW2025 #AMR #Antibiotics #STIs
📊 2025 Milestone from our SBIs programme
GARDP has signed an agreement with Bugworks Research to co-develop an oral version of BWC0977, a promising broad-spectrum antibiotic.
#WAAW2025
GARDP has signed an agreement with Bugworks Research to co-develop an oral version of BWC0977, a promising broad-spectrum antibiotic.
#WAAW2025
November 18, 2025 at 3:59 PM
📊 2025 Milestone from our SBIs programme
GARDP has signed an agreement with Bugworks Research to co-develop an oral version of BWC0977, a promising broad-spectrum antibiotic.
#WAAW2025
GARDP has signed an agreement with Bugworks Research to co-develop an oral version of BWC0977, a promising broad-spectrum antibiotic.
#WAAW2025
As part of #WAAW2025, GARDP joined the SPEARHEAD event on sustaining the fight against AMR.
Peter Beyer spoke on our R&D and access model, and Damien Somé moderated a panel on AMR’s impact and future preparedness.
📸 Jasmin Frei Fotografin Zürich
Peter Beyer spoke on our R&D and access model, and Damien Somé moderated a panel on AMR’s impact and future preparedness.
📸 Jasmin Frei Fotografin Zürich
November 18, 2025 at 2:00 PM
As part of #WAAW2025, GARDP joined the SPEARHEAD event on sustaining the fight against AMR.
Peter Beyer spoke on our R&D and access model, and Damien Somé moderated a panel on AMR’s impact and future preparedness.
📸 Jasmin Frei Fotografin Zürich
Peter Beyer spoke on our R&D and access model, and Damien Somé moderated a panel on AMR’s impact and future preparedness.
📸 Jasmin Frei Fotografin Zürich
🏥 Serious bacterial infections remain a leading cause of death in healthcare settings.
THIS IS BIG and GARDP is advancing new treatments for both children and adults.
📢 Share and join the #ThisIsBig campaign.
🔗https://gardp.pulse.ly/xhmaju3qfi
#WAAW2025 #AMR #Antibiotics #ThisIsBig
THIS IS BIG and GARDP is advancing new treatments for both children and adults.
📢 Share and join the #ThisIsBig campaign.
🔗https://gardp.pulse.ly/xhmaju3qfi
#WAAW2025 #AMR #Antibiotics #ThisIsBig
November 18, 2025 at 1:00 PM
🏥 Serious bacterial infections remain a leading cause of death in healthcare settings.
THIS IS BIG and GARDP is advancing new treatments for both children and adults.
📢 Share and join the #ThisIsBig campaign.
🔗https://gardp.pulse.ly/xhmaju3qfi
#WAAW2025 #AMR #Antibiotics #ThisIsBig
THIS IS BIG and GARDP is advancing new treatments for both children and adults.
📢 Share and join the #ThisIsBig campaign.
🔗https://gardp.pulse.ly/xhmaju3qfi
#WAAW2025 #AMR #Antibiotics #ThisIsBig
Serious bacterial infections cause 7.7M deaths every year.
Drug resistance is outpacing innovation, leaving few safe treatments.
François Franceschi explains how GARDP is acting now to change this.
#WAAW2025 #AMR #Antibiotics
Drug resistance is outpacing innovation, leaving few safe treatments.
François Franceschi explains how GARDP is acting now to change this.
#WAAW2025 #AMR #Antibiotics
November 18, 2025 at 9:01 AM
Serious bacterial infections cause 7.7M deaths every year.
Drug resistance is outpacing innovation, leaving few safe treatments.
François Franceschi explains how GARDP is acting now to change this.
#WAAW2025 #AMR #Antibiotics
Drug resistance is outpacing innovation, leaving few safe treatments.
François Franceschi explains how GARDP is acting now to change this.
#WAAW2025 #AMR #Antibiotics
🚀 Today kicks off World AMR Awareness Week 2025!
Drug-resistant infections are one of the biggest threats to global health, but action is growing worldwide.
All week we’ll share how GARDP is working with partners to develop & deliver the antibiotics we urgently need.
@who.int
#WAAW2025
Drug-resistant infections are one of the biggest threats to global health, but action is growing worldwide.
All week we’ll share how GARDP is working with partners to develop & deliver the antibiotics we urgently need.
@who.int
#WAAW2025
November 18, 2025 at 5:59 AM
🚨 Final Day to Submit!
Today’s your last chance to send in your abstract for #ACC2026.
🕔Deadline: 1700 GMT
Oral & Poster submissions are welcome. Share your research with a global audience advancing the fight against #AMR.
👉 Submit before time runs out: acc-conference.com#posters
Today’s your last chance to send in your abstract for #ACC2026.
🕔Deadline: 1700 GMT
Oral & Poster submissions are welcome. Share your research with a global audience advancing the fight against #AMR.
👉 Submit before time runs out: acc-conference.com#posters
November 14, 2025 at 10:43 AM
🚨 Final Day to Submit!
Today’s your last chance to send in your abstract for #ACC2026.
🕔Deadline: 1700 GMT
Oral & Poster submissions are welcome. Share your research with a global audience advancing the fight against #AMR.
👉 Submit before time runs out: acc-conference.com#posters
Today’s your last chance to send in your abstract for #ACC2026.
🕔Deadline: 1700 GMT
Oral & Poster submissions are welcome. Share your research with a global audience advancing the fight against #AMR.
👉 Submit before time runs out: acc-conference.com#posters
🎤 GARDP is partnering with Swissnex India for the AMR Poetry Slam & Open Mic.
Join us online on 21 Nov 2025 (4:30–6:00 PM IST) for a cross-cultural celebration of poetry, performance & action against antimicrobial resistance.
Register here: bit.ly/49Sd7hg
Join us online on 21 Nov 2025 (4:30–6:00 PM IST) for a cross-cultural celebration of poetry, performance & action against antimicrobial resistance.
Register here: bit.ly/49Sd7hg
November 14, 2025 at 7:04 AM
🎤 GARDP is partnering with Swissnex India for the AMR Poetry Slam & Open Mic.
Join us online on 21 Nov 2025 (4:30–6:00 PM IST) for a cross-cultural celebration of poetry, performance & action against antimicrobial resistance.
Register here: bit.ly/49Sd7hg
Join us online on 21 Nov 2025 (4:30–6:00 PM IST) for a cross-cultural celebration of poetry, performance & action against antimicrobial resistance.
Register here: bit.ly/49Sd7hg
🎥 How can we develop new antibiotics and ensure equitable access worldwide?
In this new interview by Global Health Centre, GARDP’s Jennifer Cohn and Peter Beyer discuss our not-for-profit R&D model and how cross-sector partnerships can drive antibiotic innovation.
Watch now 👇
bit.ly/47WwZNT
In this new interview by Global Health Centre, GARDP’s Jennifer Cohn and Peter Beyer discuss our not-for-profit R&D model and how cross-sector partnerships can drive antibiotic innovation.
Watch now 👇
bit.ly/47WwZNT
GARDP’s not-for-profit R&D model for antibiotics | Global Health R&D interview series
YouTube video by Global Health Centre
youtu.be
November 12, 2025 at 11:48 AM
🎥 How can we develop new antibiotics and ensure equitable access worldwide?
In this new interview by Global Health Centre, GARDP’s Jennifer Cohn and Peter Beyer discuss our not-for-profit R&D model and how cross-sector partnerships can drive antibiotic innovation.
Watch now 👇
bit.ly/47WwZNT
In this new interview by Global Health Centre, GARDP’s Jennifer Cohn and Peter Beyer discuss our not-for-profit R&D model and how cross-sector partnerships can drive antibiotic innovation.
Watch now 👇
bit.ly/47WwZNT
Make sure to join experts at the Antimicrobial Resistance Symposium 2025 hosted by Charité - Universitätsmedizin Berlin, focused on tackling Carbapenem-Resistant Enterobacterales (#CRE)
📍Berlin & online
🗓️ 21 Nov 2025
More details here: bit.ly/47C57zu
📍Berlin & online
🗓️ 21 Nov 2025
More details here: bit.ly/47C57zu
November 12, 2025 at 9:14 AM
Make sure to join experts at the Antimicrobial Resistance Symposium 2025 hosted by Charité - Universitätsmedizin Berlin, focused on tackling Carbapenem-Resistant Enterobacterales (#CRE)
📍Berlin & online
🗓️ 21 Nov 2025
More details here: bit.ly/47C57zu
📍Berlin & online
🗓️ 21 Nov 2025
More details here: bit.ly/47C57zu
Reposted by Global Antibiotic R&D Partnership (GARDP)
If you weren't able to attend #GAMRIC2025, or you want to catch up on sessions you missed, a comprehensive round-up is now live, covering each session of the conference in detail ➡️ https://www.gamric.org/about-gamric/conference-round-up/
@carb-x.bsky.social @escmid.bsky.social @gardp.bsky.social
@carb-x.bsky.social @escmid.bsky.social @gardp.bsky.social
Conference round-up
www.gamric.org
November 11, 2025 at 9:15 AM
If you weren't able to attend #GAMRIC2025, or you want to catch up on sessions you missed, a comprehensive round-up is now live, covering each session of the conference in detail ➡️ https://www.gamric.org/about-gamric/conference-round-up/
@carb-x.bsky.social @escmid.bsky.social @gardp.bsky.social
@carb-x.bsky.social @escmid.bsky.social @gardp.bsky.social
Reposted by Global Antibiotic R&D Partnership (GARDP)
Antimicrobial resistance (AMR) is a growing global health crisis. Presenters and participants discuss the complexities of AMR and explore innovative approaches and story ideas to enhance meaningful media coverage.
#WCSJ2025 #letstalksciencejournalism @wfsj25.bsky.social @gardp.bsky.social
#WCSJ2025 #letstalksciencejournalism @wfsj25.bsky.social @gardp.bsky.social
November 10, 2025 at 8:16 AM
Antimicrobial resistance (AMR) is a growing global health crisis. Presenters and participants discuss the complexities of AMR and explore innovative approaches and story ideas to enhance meaningful media coverage.
#WCSJ2025 #letstalksciencejournalism @wfsj25.bsky.social @gardp.bsky.social
#WCSJ2025 #letstalksciencejournalism @wfsj25.bsky.social @gardp.bsky.social
War is pushing us to a drug resistance tipping point.
In his latest piece for @financialtimes.com, GARDP’s Manica Balasegaram highlights how the failure to prevent the rise and spread of infections in conflict zones imperils health security everywhere.
Read more 👇
www.ft.com/content/978b...
In his latest piece for @financialtimes.com, GARDP’s Manica Balasegaram highlights how the failure to prevent the rise and spread of infections in conflict zones imperils health security everywhere.
Read more 👇
www.ft.com/content/978b...
War is pushing us to a drug resistance tipping point
Failure to prevent the rise and spread of infections in conflict zones imperils health security everywhere
www.ft.com
November 6, 2025 at 4:34 PM
War is pushing us to a drug resistance tipping point.
In his latest piece for @financialtimes.com, GARDP’s Manica Balasegaram highlights how the failure to prevent the rise and spread of infections in conflict zones imperils health security everywhere.
Read more 👇
www.ft.com/content/978b...
In his latest piece for @financialtimes.com, GARDP’s Manica Balasegaram highlights how the failure to prevent the rise and spread of infections in conflict zones imperils health security everywhere.
Read more 👇
www.ft.com/content/978b...
📢 10 days left to submit abstracts for #ACC2026!
Researchers and professionals at the forefront of #AMR will present their work at our virtual open access conference on 4-5 February 2026.
Submit your abstract by 1700 GMT on 14 November 2025 via our online submission form.
🔗https://bit.ly/4hHLJVb
Researchers and professionals at the forefront of #AMR will present their work at our virtual open access conference on 4-5 February 2026.
Submit your abstract by 1700 GMT on 14 November 2025 via our online submission form.
🔗https://bit.ly/4hHLJVb
November 5, 2025 at 7:06 AM